Cubist Systematic Strategies’s Amylyx Pharmaceuticals AMLX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $790K | Buy |
123,242
+40,112
| +48% | +$257K | ﹤0.01% | 952 |
|
|
2025
Q1 | $294K | Sell |
83,130
-389,267
| -82% | -$1.38M | ﹤0.01% | 1122 |
|
|
2024
Q4 | $1.79M | Buy |
472,397
+423,316
| +862% | +$1.6M | 0.01% | 633 |
|
|
2024
Q3 | $159K | Sell |
49,081
-117,467
| -71% | -$381K | ﹤0.01% | 1179 |
|
|
2024
Q2 | $316K | Sell |
166,548
-9,566
| -5% | -$18.2K | ﹤0.01% | 1020 |
|
|
2024
Q1 | $500K | Sell |
176,114
-260,721
| -60% | -$740K | ﹤0.01% | 1383 |
|
|
2023
Q4 | $6.43M | Buy |
436,835
+236,645
| +118% | +$3.48M | 0.04% | 372 |
|
|
2023
Q3 | $3.67M | Buy |
200,190
+145,942
| +269% | +$2.67M | 0.03% | 554 |
|
|
2023
Q2 | $1.17M | Sell |
54,248
-9,750
| -15% | -$210K | 0.01% | 1110 |
|
|
2023
Q1 | $1.88M | Buy |
63,998
+60,192
| +1,582% | +$1.77M | 0.01% | 1158 |
|
|
2022
Q4 | $141K | Sell |
3,806
-298
| -7% | -$11K | ﹤0.01% | 2770 |
|
|
2022
Q3 | $116K | Sell |
4,104
-48,896
| -92% | -$1.38M | ﹤0.01% | 3179 |
|
|
2022
Q2 | $1.02M | Buy |
53,000
+18,086
| +52% | +$348K | 0.01% | 2107 |
|
|
2022
Q1 | $449K | Buy |
+34,914
| New | +$449K | ﹤0.01% | 2580 |
|